Satter Management Co., L.P. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $57.4 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Annexon, Inc. with a value of $43.8M, Akebia Therapeutics, Inc. with a value of $7.59M, Verona Pharma PLC with a value of $5.92M, American Well Corp with a value of $0, and Aadi Bioscience, Inc. with a value of $1K.

Examining the 13F form we can see an increase of $6.39M in the current position value, from $51M to 57.4M.

Below you can find more details about Satter Management Co., L.P. portfolio as well as his latest detailed transactions.

Portfolio value $57.4 Million
Healthcare: $57.4 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $57.4 Million
  • Prior Value $51 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Satter Management Co., L.P. Portfolio

Follow Satter Management Co., L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Satter Management Co., L.P., based on Form 13F filings with the SEC.

News

Stay updated on Satter Management Co., L.P. with notifications on news.